Efficacy and safety of neoadjuvant chemotherapy with modified FOLFOX7 regimen on the treatment of advanced gastric cancerOACSCDCSTPCD
Efficacy and safety of neoadjuvant chemotherapy with modified FOLFOX7 regimen on the treatment of advanced gastric cancer
Background Gastric cancer is one of the most common types of malignant tumors in China and East Asia and has the highest mortality rate of the malignant gastrointestinal tumors.Neoadjuvant chemotherapy is a systemic or local chemotherapy that is given prior to the local treatment of malignant tumors.Neoadjuvant therapy is currently showing some positive prospects; however,its clinical effects remain controversial.In this study,we used the modified FOLFO×7 (m…查看全部>>
ZHANG Jun;CHEN Ren-xiong;ZHANG Jing;CAI Jun;MENG Hua;WU Guo-cong;ZHANG Zhong-tao;WANG Yu;WANG Kang-li
Department of General Surgery,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,ChinaDepartment of General Surgery,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,ChinaDepartment of General Surgery,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,ChinaDepartment of General Surgery,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,ChinaDepartment of General Surgery,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,ChinaDepartment of General Surgery,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,ChinaDepartment of General Surgery,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,ChinaDepartment of General Surgery,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,ChinaDepartment of General Surgery,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,China
neoadjuvant chemotherapyadvanced gastric cancerefficacysafety
neoadjuvant chemotherapyadvanced gastric cancerefficacysafety
《中华医学杂志（英文版）》 2012 (12)
2144-2150,7
评论